Atlas Trials

Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

RecordFirmDate
JAK2 Mutation May Predict Response and Guide First Line Treatment in Rheumatoid Arthritis (NCT04667988)Mansoura University2019-01-01

Track Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression automatically

Every clearance here is in the API, with alerts when new ones post.